(2S,3R)-2-Carboxy-3-(3-chlorophenyl)pyrrolidin-1-ium Hydrochloride

ID: ALA4076785

Chembl Id: CHEMBL4076785

PubChem CID: 137652319

Max Phase: Preclinical

Molecular Formula: C11H13Cl2NO2

Molecular Weight: 225.68

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cl.O=C(O)[C@H]1NCC[C@@H]1c1cccc(Cl)c1

Standard InChI:  InChI=1S/C11H12ClNO2.ClH/c12-8-3-1-2-7(6-8)9-4-5-13-10(9)11(14)15;/h1-3,6,9-10,13H,4-5H2,(H,14,15);1H/t9-,10+;/m1./s1

Standard InChI Key:  PKKNPVKIMCGTHK-UXQCFNEQSA-N

Associated Targets(non-human)

Grik1 Glutamate receptor ionotropic kainate 1 (319 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grik2 Glutamate receptor ionotropic kainate 2 (298 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grik3 Glutamate receptor ionotropic kainate 3 (207 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 225.68Molecular Weight (Monoisotopic): 225.0557AlogP: 1.87#Rotatable Bonds: 2
Polar Surface Area: 49.33Molecular Species: ZWITTERIONHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 1.51CX Basic pKa: 11.29CX LogP: -0.47CX LogD: -0.47
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.81Np Likeness Score: 0.08

References

1. Gynther M, Proietti Silvestri I, Hansen JC, Hansen KB, Malm T, Ishchenko Y, Larsen Y, Han L, Kayser S, Auriola S, Petsalo A, Nielsen B, Pickering DS, Bunch L..  (2017)  Augmentation of Anticancer Drug Efficacy in Murine Hepatocellular Carcinoma Cells by a Peripherally Acting Competitive N-Methyl-d-aspartate (NMDA) Receptor Antagonist.,  60  (23): [PMID:29205034] [10.1021/acs.jmedchem.7b01624]

Source